Mills Kenneth T. bought RGNX
January 27, 2026 · Form 4 insider transaction
Mills Kenneth T. bought 225,000 shares of REGENXBIO Inc. at $13.09 per share, a transaction worth $2.95M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
225,000
Price
$13.09
Total value
$2.95M
InsiderMills Kenneth T.
RoleDirector
CompanyREGENXBIO Inc. (RGNX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 27, 2026
Filing dateJanuary 29, 2026
Shares owned after707,871
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The previously granted option, representing a right to purchase a total of 225,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter.